Back
Back

iShares Healthcare Innovation

Global healthcare companies

(DRDR)
£6.14
Previous business day’s close price
‑£1.36 (‑18.13%)
max available period
£5
£8.14
04 Jan 21
13 Dec 24

Details

ETF description

The iShares Healthcare Innovation ETF is designed to provide investors with exposure to companies that are at the forefront of technological advancements and innovation within the healthcare sector. By tracking the NYSE FactSet Global Healthcare Innovators index, this ETF focuses on firms involved in pioneering medical technologies, biotechnology, pharmaceuticals, and healthcare services, aiming to capture the growth potential from the latest advancements in healthcare.

Issuer details

iShares ETFs are issued and managed by BlackRock, the world’s largest asset management company.

With 800+ products globally and over $2trn in assets (as at June 2024), iShares ETFs are a flexible, low‑cost way for investors to gain exposure to various market segments, including fixed income, emerging markets and broad‑based indexes.

Index details

The Healthcare Innovation index offers specialized exposure to companies that are leading the way in healthcare advancements and breakthroughs. By focusing on innovative technologies, treatments, and solutions, the index aims to deliver growth potential and investment opportunities driven by the latest trends in healthcare. It serves as a valuable tool for investors seeking to capitalize on the transformative impact of healthcare innovation while benefiting from diversified exposure to cutting‑edge developments in the sector.

This ETF is in collections:

Thematics
Healthcare

Key information

Key investor information

ETF Breakdown

Region
Sector
argenx SE
2.5%
Natera Inc
2.2%
Gilead Sciences, Inc.
2.1%
Insulet Corporation
2.0%
UCB SA
2.0%
Bristol‑Myers Squibb Co.
2.0%
Intuitive Surgical Inc
1.9%
Illumina Inc
1.8%
Boston Scientific Corp.
1.7%
Abbott Laboratories
1.6%
Lonza Group AG
1.6%
Samsung Biologics Co Ltd
1.6%
Abbvie Inc
1.6%
Agilent Technologies Inc.
1.5%
Hologic, Inc.
1.5%
Medtronic Plc
1.5%
Sarepta Therapeutics Inc
1.5%
Johnson & Johnson
1.5%
Exact Sciences Corp.
1.4%
Catalent Inc.
1.4%
Novartis AG
1.4%
Bio‑Techne Corp
1.4%
Sysmex Corporation
1.4%
Neurocrine Biosciences, Inc.
1.4%
Exelixis Inc
1.4%
BeiGene Ltd
1.4%
IQVIA
1.4%
Celltrion Inc
1.4%
Pfizer Inc.
1.4%
AMGEN Inc.
1.3%
Thermo Fisher
1.3%
Danaher Corp.
1.3%
Charles River Laboratories International Inc.
1.3%
Qiagen N.V.
1.3%
Edwards Lifesciences Corp
1.2%
GSK Plc
1.2%
Genmab
1.2%
Pro Medicus
1.2%
Merck & Co Inc
1.2%
Shimadzu Corporation
1.1%
Biogen Inc
1.0%
Eisai Co Ltd
1.0%
Medpace Holdings Inc
1.0%
Dexcom Inc
1.0%
Revolution Medicines Inc
1.0%
Intra‑Cellular Therapies Inc
1.0%
Repligen Corp.
0.9%
Bio‑Rad Laboratories Inc.
0.9%
Halozyme Therapeutics Inc.
0.8%
Lantheus Holdings Inc
0.8%
Zealand Pharma A/S.
0.8%
Sartorius AG
0.7%
Alkermes plc
0.7%
Ionis Pharmaceuticals Inc
0.7%
Biomerieux
0.6%
Siegfried Holding AG
0.6%
TG Therapeutics Inc
0.6%
Asahi Intecc Co. Ltd.
0.6%
Guardant Health Inc
0.6%
Maximus Inc.
0.6%
Ipsen
0.5%
Sectra Class B
0.5%
BridgeBio Pharma Inc
0.5%
Axsome Therapeutics Inc
0.5%
PTC Therapeutics Inc
0.5%
Akeso Inc
0.5%
Corvel Corp.
0.5%
Moderna Inc
0.4%
Rhythm Pharmaceuticals Inc.
0.4%
Veracyte Inc
0.4%
Tecan Group AG
0.4%
Arcellx Inc
0.4%
Denali Therapeutics Inc
0.4%
Diasorin S.p.A.
0.4%
LivaNova PLC
0.3%
Twist Bioscience Corp
0.3%
Neogen Corp.
0.3%
Catalyst Pharmaceuticals Inc
0.3%
NovoCure Ltd
0.3%
Bachem Holding AG
0.3%
Merus N.V
0.3%
Nurix Therapeutics Inc
0.3%
Bavarian Nordic A/S
0.3%
Elekta AB (publ)
0.3%
Geron Corp.
0.3%
Ligand Pharmaceuticals, Inc.
0.3%
SK Biopharmaceuticals Co. Ltd.
0.3%
Fortrea Holdings Inc
0.3%
Supernus Pharmaceuticals Inc
0.3%
Acadia Pharmaceuticals Inc
0.3%
Ideaya Biosciences Inc
0.3%
Tandem Diabetes Care Inc
0.3%
JEOL Ltd.
0.2%
Lion Biotechnologies Inc
0.2%
QuidelOrtho Corporation
0.2%
Sawai Group Holdings Co Ltd
0.2%
HUTCHMED (China) Limited
0.2%
Apollo Medical Holdings Inc
0.2%
Beam Therapeutics Inc
0.2%
H. Lundbeck AS
0.2%
Atricure Inc
0.2%
Biocryst Pharmaceuticals Inc.
0.2%
Dynavax Technologies Corp.
0.2%
10x Genomics Inc
0.2%
Arvinas Operations Inc
0.2%
Integra Lifesciences Holdings Corp
0.2%
Xencor Inc
0.2%
Evotec SE
0.2%
Myriad Genetics, Inc.
0.2%
United Laboratories International Holdings Ltd.
0.2%
ANI Pharmaceuticals Inc
0.2%
Caredx Inc
0.2%
Harmony Biosciences Holdings Inc
0.2%
Oxford Nanopore Technologies Plc
0.2%
Peptron Inc.
0.2%
Certara Inc
0.1%
Chemometec AS
0.1%
Evolent Health Inc
0.1%
Schrodinger Inc
0.1%
Blk Ics Usd Liq Agency Dis
0.1%
Galapagos NV
0.1%
Lunit Inc
0.1%
Neuren Pharmaceuticals Ltd
0.1%
Pharmamar S.A.
0.1%
Recursion Pharmaceuticals Inc
0.1%
Novavax, Inc.
0.1%
Xvivo Perfusion AB
0.1%
Zymeworks Inc
0.1%
Adaptive Biotechnologies Corp
0.1%
Castle Biosciences Inc
0.1%
Cytek BioSciences Inc
0.1%
ImmunityBio Inc
0.1%
Keymed Biosciences Inc.
0.1%
SK bioscience Co. Ltd.
0.1%
Vir Biotechnology Inc
0.1%
Avid Bioservices Inc
0.1%
Seegene Inc
0.1%
ABL Bio Inc.
< 0.1%
Arcus Biosciences Inc
< 0.1%
BioArctic AB
< 0.1%
Prothena Corporation plc
< 0.1%
AbCellera Biologics Inc
< 0.1%
Axogen Inc.
< 0.1%
ST Pharm Co Ltd
< 0.1%
Eiken Chemical Co Ltd
< 0.1%
Japan Lifeline Co Ltd
< 0.1%
Maravai LifeSciences Holdings Inc
< 0.1%
Pacific Biosciences of California Inc
< 0.1%
Polaris Group
< 0.1%
Relay Therapeutics Inc
< 0.1%
CompuGroup Medical SE & Co. KgaA
< 0.1%
Pharming Group N.V.
< 0.1%
Roche Holding AG
< 0.1%
SD Biosensor Inc.
< 0.1%
Simulations Plus Inc.
< 0.1%
Tobii Dynavox AB
< 0.1%
AnaptysBio Inc
< 0.1%
Arcturus Therapeutics Holdings Inc
< 0.1%
Quanterix Corp
< 0.1%
RemeGen Co. Ltd.
< 0.1%
Y‑Mabs Therapeutics Inc
< 0.1%
4D Molecular Therapeutics Inc
< 0.1%
Allogene Therapeutics Inc
< 0.1%
ITeos Therapeutics Inc
< 0.1%
Mersana Therapeutics Inc
< 0.1%
Orasure Technologies Inc.
< 0.1%
Regenxbio Inc
< 0.1%
Sage Therapeutics Inc
< 0.1%
Shinpoong Pharmaceutical
< 0.1%
Sillajen Biotherapeutics Inc
< 0.1%
Stoke Therapeutics Inc
< 0.1%
Takara Bio Inc.
< 0.1%
UroGen Pharma Ltd
< 0.1%
Vanda Pharmaceuticals Inc
< 0.1%
uniQure N.V.
< 0.1%
ATAI Life Sciences N.V.
< 0.1%
Accolade Inc
< 0.1%
Fate Therapeutics Inc
< 0.1%
Macrogenics Inc
< 0.1%
Shanghai Junshi Biosciences Co Ltd
< 0.1%
Venus Medtech (Hangzhou) Inc.
< 0.1%
Alector Inc
< 0.1%
Caribou Biosciences Inc
< 0.1%
Cellivery Therapeutics Inc.
< 0.1%
I‑Sens USA Inc
< 0.1%
Idorsia Ltd
< 0.1%
Lyell Immunopharma Inc
< 0.1%
Nevro Corp
< 0.1%
PHC Holdings Corporation
< 0.1%
Sutro Biopharma Inc
< 0.1%
Valneva SE
< 0.1%
Agenus Inc
< 0.1%
Nkmax Co. Ltd
< 0.1%
Others
< 0.1%
£6.14
Previous business day’s close price

Capital at risk

Why InvestEngine

Unbeatable value

From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it

Choice of 700+ ETFs

Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
Browse investments

Actionable insights

Know exactly which companies, sectors and regions are in your portfolio.

Powerful automation

Grow your wealth the easy way with automated investing features

Easy diversification

Fractional investing lets you put as little as £1 in any ETF.

DIY or Managed

Build and manage your own portfolio or leave it to us.

ETFs have spreads and annual charges and come with risks like market volatility, liquidity, and concentration, and may not always accurately track their index. Past performance and forecasts are not reliable indicators of future results. The value of your investments, including any income, can rise or fall. You may get back less than you originally invested.
Our support is available Monday-Friday 5:30am to 9:00pm
and Saturday-Sunday 8:30am to 5:30pm
Why InvestEngine
Accounts
Compare
Portfolios
Calculators
Legal information
Our Address
InvestEngine (UK) Limited, 4th Floor, 57 Great Suffolk Street, London, SE1 0BB
Why InvestEngine
Accounts
Portfolios
Calculators
Compare
Legal information
Our Address
InvestEngine (UK) Limited, 4th Floor, 57 Great Suffolk Street, London, SE1 0BB
Facebook
Twitter
Linkedin
Instagram
Community
Visit our blog at blog.investengine.com
Whenever you invest, your capital is at risk
This could mean the value of your investments goes down as well as up.
Understand more about investment risk.
© InvestEngine Limited 2024. All rights reserved.

Capital at risk